199 related articles for article (PubMed ID: 9199412)
1. Localization of intravenously administered verocytotoxins (Shiga-like toxins) 1 and 2 in rabbits immunized with homologous and heterologous toxoids and toxin subunits.
Bielaszewska M; Clarke I; Karmali MA; Petric M
Infect Immun; 1997 Jul; 65(7):2509-16. PubMed ID: 9199412
[TBL] [Abstract][Full Text] [Related]
2. Cross-protection against challenge by intravenous Escherichia coli verocytotoxin 1 (VT1) in rabbits immunized with VT2 toxoid.
Ludwig K; Karmali MA; Smith CR; Petric M
Can J Microbiol; 2002 Jan; 48(1):99-103. PubMed ID: 11888169
[TBL] [Abstract][Full Text] [Related]
3. Toxicity and immunogenicity of a verotoxin 1 mutant with reduced globotriaosylceramide receptor binding in rabbits.
Bast DJ; Brunton JL; Karmali MA; Richardson SE
Infect Immun; 1997 Jun; 65(6):2019-28. PubMed ID: 9169727
[TBL] [Abstract][Full Text] [Related]
4. Protection against verocytotoxin in mice induced by liposome-coupled verocytotoxin.
Naito S; Horino A; Komiya T; Fukuda Y; Takahashi M; Ami Y; Suzaki Y; Satoh S; Gondaira F; Sugiyama J; Nakano Y; Mori M; Awai K; Nishinohara S; Komuro K; Uchida T
Int Arch Allergy Immunol; 1997 Nov; 114(3):293-7. PubMed ID: 9363912
[TBL] [Abstract][Full Text] [Related]
5. Production and characterisation of monoclonal antibodies to Verotoxins 1 and 2 from Escherichia coli of serotype O 157:H7.
Padhye VV; Zhao T; Doyle MP
J Med Microbiol; 1989 Nov; 30(3):219-26. PubMed ID: 2479749
[TBL] [Abstract][Full Text] [Related]
6. Experimental verocytotoxemia in rabbits.
Richardson SE; Rotman TA; Jay V; Smith CR; Becker LE; Petric M; Olivieri NF; Karmali MA
Infect Immun; 1992 Oct; 60(10):4154-67. PubMed ID: 1398926
[TBL] [Abstract][Full Text] [Related]
7. Preparation of VT1 and VT2 hybrid toxins from their purified dissociated subunits. Evidence for B subunit modulation of a subunit function.
Head SC; Karmali MA; Lingwood CA
J Biol Chem; 1991 Feb; 266(6):3617-21. PubMed ID: 1847382
[TBL] [Abstract][Full Text] [Related]
8. Binding of Escherichia coli verotoxins to cell surface protein on wild-type and globotriaosylceramide-deficient Vero cells.
Devenish J; Gyles C; LaMarre J
Can J Microbiol; 1998 Jan; 44(1):28-34. PubMed ID: 9522446
[TBL] [Abstract][Full Text] [Related]
9. Differences in verotoxin neutralizing activity of therapeutic immunoglobulins and sera from healthy controls.
Bitzan M; Klemt M; Steffens R; Müller-Wiefel DE
Infection; 1993; 21(3):140-5. PubMed ID: 8365810
[TBL] [Abstract][Full Text] [Related]
10. Effect of verocytotoxins (Shiga-like toxins) on human neutrophils in vitro.
Holle JU; Williams JM; Harper L; Savage CO; Taylor CM
Pediatr Nephrol; 2005 Sep; 20(9):1237-44. PubMed ID: 15947986
[TBL] [Abstract][Full Text] [Related]
11. Rapid and specific detection of verotoxin genes in Escherichia coli by the polymerase chain reaction.
Pollard DR; Johnson WM; Lior H; Tyler SD; Rozee KR
J Clin Microbiol; 1990 Mar; 28(3):540-5. PubMed ID: 2182671
[TBL] [Abstract][Full Text] [Related]
12. Genetic toxoids of Shiga toxin types 1 and 2 protect mice against homologous but not heterologous toxin challenge.
Wen SX; Teel LD; Judge NA; O'Brien AD
Vaccine; 2006 Feb; 24(8):1142-8. PubMed ID: 16198455
[TBL] [Abstract][Full Text] [Related]
13. Ability of human sera to neutralise the activity of Vero cytotoxins VT1, VT2 and variant forms of VT2.
Scotland SM; Said B; Thomas A; Rowe B
FEMS Microbiol Lett; 1994 Jan; 115(2-3):285-9. PubMed ID: 8138140
[TBL] [Abstract][Full Text] [Related]
14. Immunization of pigs with a purified Shiga-like toxin II variant toxoid.
MacLeod DL; Gyles CL
Vet Microbiol; 1991 Nov; 29(3-4):309-18. PubMed ID: 1837635
[TBL] [Abstract][Full Text] [Related]
15. Alteration of the glycolipid binding specificity of the pig edema toxin from globotetraosyl to globotriaosyl ceramide alters in vivo tissue targetting and results in a verotoxin 1-like disease in pigs.
Boyd B; Tyrrell G; Maloney M; Gyles C; Brunton J; Lingwood C
J Exp Med; 1993 Jun; 177(6):1745-53. PubMed ID: 8496689
[TBL] [Abstract][Full Text] [Related]
16. Genes coding for Shiga-like toxins in bovine verotoxin-producing Escherichia coli (VTEC) strains belonging to different O:K:H serotypes.
Blanco M; Blanco J; Blanco JE; González EA; Gomes TA; Zerbini LF; Yano T; de Castro AF
Vet Microbiol; 1994 Nov; 42(2-3):105-10. PubMed ID: 7886925
[TBL] [Abstract][Full Text] [Related]
17. Isolation and some properties of A and B subunits of Vero toxin 2 and in vitro formation of hybrid toxins between subunits of Vero toxin 1 and Vero toxin 2 from Escherichia coli O157:H7.
Ito H; Yutsudo T; Hirayama T; Takeda Y
Microb Pathog; 1988 Sep; 5(3):189-95. PubMed ID: 3063913
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of a microplate latex agglutination method (Verotox-F assay) for detecting and characterizing verotoxins (Shiga toxins) in Escherichia coli.
Karmali MA; Petric M; Bielaszewska M
J Clin Microbiol; 1999 Feb; 37(2):396-9. PubMed ID: 9889226
[TBL] [Abstract][Full Text] [Related]
19. Neutralizing activity of bovine colostral antibody against verotoxin derived from enterohemorrhagic Escherichia coli O157:H7 in mice.
Kuribayashi T; Seita T; Fukuyama M; Furuhata K; Honda M; Matsumoto M; Seguchi H; Yamamoto S
J Infect Chemother; 2006 Oct; 12(5):251-6. PubMed ID: 17109087
[TBL] [Abstract][Full Text] [Related]
20. Globotriosyl ceramide is specifically recognized by the Escherichia coli verocytotoxin 2.
Waddell T; Head S; Petric M; Cohen A; Lingwood C
Biochem Biophys Res Commun; 1988 Apr; 152(2):674-9. PubMed ID: 3284526
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]